英国的试验显示免疫疗法可以预防肠癌复发. UK trial shows immunotherapy prevents bowel cancer relapse.

一项新的研究显示,对于患有一种特定类型的肠癌患者来说, 结果很有希望. A new study shows promising results for patients with a specific type of bowel cancer. 英国的一项试验发现,在手术前接受短时间免疫疗法的32名患者近三年内没有癌症,而且没有报告复发. A UK trial found that 32 patients who received a short course of immunotherapy before surgery remained cancer-free for nearly three years, with no relapses reported. 这种方法显示出与标准治疗相比显著改善, 典型的复发率为25%. This approach showed significant improvement over the standard treatment, which typically has a 25% relapse rate.